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INTRODUCTION
Drugs, latex, and disinfectants are major causes of occupation-
al allergic diseases in health care workers (HCW) in hospitals.
1,2 
Drugs are one of the most common causes of allergic diseases 
in HCW, including nurses and pharmacists, who both work with 
drugs.
3-9 HCW in hospitals are commonly exposed to beta-lac-
tam antibiotics, such as penicillins and cephalosporins. Occu-
pational allergic diseases caused by these agents, including 
bronchial asthma, allergic contact dermatitis, and contact urti-
caria syndrome, have been frequently reported.
3-7,10,11 An IgE-
mediated mechanism has been suggested for contact urticaria 
syndrome, which includes urticaria and anaphylaxis induced 
by beta-lactam antibiotics.
3,4 
A few published studies have used skin prick tests (SPTs) to 
determine sensitization rates to beta-lactam antibiotics in HCW. 
The sensitization rate to beta-lactam antibiotics by SPT was 2.6% 
in hospital nurses, and the prevalence of contact urticaria syn-
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drome associated with beta-lactam antibiotics was 8.9%.
12 In 
hospital nurses without a history of penicillin allergy, the sensi-
tization rate by SPT to penicillins was 12%.
13 In recent years, 
cephalosporins have been more commonly prescribed than 
penicillins in major hospitals in this country. Therefore, we in-
vestigated the sensitization rates to commonly used cephalo-
sporins in HCW in a single university hospital. We used two 
methods: SPT and measurement of specific IgE antibodies to 
cephalosporins conjugated with human serum albumin (HSA).
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Purpose:  Cephalosporins can induce occupational allergies, such as asthma, urticaria, and anaphylaxis. We investigated the prevalence and risk 
factors of sensitization to cephalosporin.  Methods:  A total of 161 health care workers (HCW), including 138 nurses and 23 pharmacists, and 86 
unexposed non-atopic healthy controls were recruited from a single tertiary hospital and the general population. A questionnaire regarding work-re-
lated symptoms was administered along with skin prick tests (SPT) to the three most commonly used cephalosporins (cefotiam, ceftriaxone, and 
ceftizoxime). Serum specific IgE antibodies to conjugates of the three cephalosporins and human serum albumin (HSA) were measured by enzyme-
linked immunosorbent assay (ELISA). Binding specificities were confirmed by ELISA inhibition tests.  Results:  The prevalence of work-related symp-
toms in association with cephalosporins was 17.4%. The sensitization rate to any cephalosporin was 3.1% by SPT. Sensitization rates determined by 
measurement of serum specific IgE antibodies were 17.4% for any cephalosporin, 10.4% for cefotiam, 6.8% for ceftriaxone, and 3.7% for ceftizox-
ime. A personal history of any antibiotic allergy was a risk factor for work-related symptoms (OR, 24.93; 95% CI, 2.61-238), but not for the presence 
of serum specific IgE antibodies to cephalosporins (OR, 0.9; 95% CI, 0.18-4.53). A personal history of atopic dermatitis was a risk factor for the pres-
ence of serum specific IgE antibodies to cefotiam-HSA conjugate (OR, 6.30; 95% CI, 1.23-32.3).  Conclusions:  A high cephalosporin sensitization 
rate (17.4%) was detected by ELISA in HCW exposed to cephalosporins. Monitoring of serum specific IgEs to cephalosporin-HSA conjugates will be 
useful for detecting sensitized subjects. 
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MATERIALS AND METHODS
Subjects
The study subjects included 161 HCW and 86 non-atopic 
healthy controls that were recruited from a single tertiary hos-
pital and the general population. The HCW consisted of 138 
nurses and 23 pharmacists. The nurses were divided into the 
following two groups: group I included 125 nurses working in 
wards where they were exposed to cephalosporins (current-ex-
posure group) and group II included 13 nurses working in out-
patient departments or in offices, who had a prior history of 
working in general wards at least six months before the study 
(previously-exposed group). The pharmacists-who were em-
ployed in the hospital pharmacy-might have been exposed to 
cephalosporins. The control subjects were healthy volunteers 
who had no history of allergic diseases or antibiotic allergy. In-
formed consent was obtained from each subject, and the study 
protocol was approved by the Institutional Review Board of the 
hospital (AJIRB-GEN-SUR-09-195).
Questionnaire
The questionnaire was a modification of that used in the Inter-
national Study on Asthma and Allergies in Childhood (ISAAC),
14 
which included workplace, use of protective equipment when 
handling cephalosporins, smoking status, duration of employ-
ment, personal history of allergic diseases, presence of work-re-
lated symptoms, and duration of the latent period. Personal 
history of allergic diseases included asthma, rhinitis, atopic der-
matitis, or any kind of antibiotic allergy. Work-related symp-
toms were defined as those that developed after handling any 
cephalosporin and consisted of upper and/or lower respiratory 
symptoms, cutaneous symptoms, and anaphylaxis. Upper and/
or lower respiratory symptoms included nasal itching, runny 
nose, sneezing, nasal congestion, cough, sputum, shortness of 
breath, or wheezing, and cutaneous symptoms included urti-
caria or dermatitis.
Cephalosporins tested
The most commonly prescribed intravenous cephalosporins, 
i.e., cefotiam, ceftriaxone, and ceftizoxime, were selected for use 
in this study. Cefotiam was purchased from CJ Pharmaceutical 
Co., Ltd (Seoul, Korea), ceftriaxone from Hanmi Pharmaceuti-
cal Co., Ltd. (Seoul, Korea), and ceftizoxime from Dong-A Phar-
maceutical Co., Ltd. (Seoul, Korea).
Skin prick tests with aeroallergens and cephalosporins
HCW and healthy controls were tested by SPTs using common 
aeroallergens and the three cephalosporins. The aeroallergens 
included Dermatophagoides farinae, tree pollens, weed pollens, 
Japanese hops, grass pollens, and cat dander (Bencard, Brent-
ford, UK). The concentration of each cephalosporin solution 
used was 10 mg/mL. Saline and 1 mg/mL histamine were used 
as negative and positive controls, respectively. Atopy was de-
fined as those subjects who showed positive responses to at 
least one common inhalant allergen on SPT.
Measurements of serum total and specific IgE antibodies to 
three cephalosporin-HSA conjugates (cefotiam, ceftriaxone, 
and ceftizoxime)
Serum total IgE antibody levels were measured using an Im-
munoCAP System (Phadia, Uppsala, Sweden). Serum specific 
IgE antibodies to cephalosporins were detected by capture en-
zyme-linked immunosorbent assay (ELISA) using cephalospo-
rin-HSA conjugates. Three cephalosporin-HSA conjugates (ce-
fotiam, ceftriaxone, and ceftizoxime) were prepared according 
to methods described previously.
3,10,15 
Cephalosporin-HSA conjugates or mock-HSA conjugate were 
dissolved in phosphate buffered saline (PBS, pH 7.4) at 10 μg/
mL. This solution (100 μL) was coated onto 96-well ELISA mi-
croplates (Corning, New York, NY, USA) for two hours at 37°C 
and the plates were placed at 4°C overnight. After washing four 
times with 350 μL PBS containing 0.05% Tween 20 (PBS-T; Sig-
ma-Aldrich, St. Louis, MO, USA), unoccupied antigen binding 
sites on the plate were blocked using 200 μL of blocking buffer 
that contained 10% fetal bovine serum (FBS; GIBCO; Invitro-
gen, Carlsbad, CA, USA) in PBS at 37°C for two hours. The plates 
were again washed four times with PBS-T, and 50 μL of three-
fold diluted serum samples in blocking buffer were added to 
the wells, and the plates were incubated for two hours at room 
temperature with shaking. The plates were washed four times 
with PBS-T, and 100 μL of goat anti-human IgE antibody (Kirkeg-
aard and Perry Laboratories, Inc., Gaithersburg, MD, USA), di-
luted 1:1,000 v/v in 10% FBS-PBS, was added to each well. The 
plates were then incubated for one hour at room temperature, 
followed by washing four times with PBS-T. A total of 100 μL of 
alkaline phosphatase-conjugated rabbit anti-goat IgG antibody 
(ReserveAP; Kirkegaard and Perry Laboratories, Inc.) diluted 
1:500 v/v in 10% FBS-PBS was added to each well, and plates 
were again incubated for one hour at room temperature. PNPP 
(100 μL; p-nitro-phenyl phosphate; Sigma-Aldrich) was added 
as the substrate. The reaction was stopped by the addition of 
100 μL of 1 N NaOH. Optical densities were measured at 405 nm 
on a microplate reader (Synergy HT; Bio Tek Instruments, Inc., 
Winooski, VT, USA). The final absorbance values of samples 
tested using cephalosporin-HSA conjugates were determined 
by subtracting the absorbance values of the same samples test-
ed on mock-HSA conjugate. Values were then multiplied by 
1,000. Positive cutoff values for the ELISAs were determined 
from the mean plus three times the standard deviation of the 
absorbance values of the non-atopic healthy controls (n=86).
IgE ELISA inhibition test
Binding specificities were confirmed by an ELISA inhibition 
test. Increasing amounts (1-100 μg/mL) of free and conjugated IgE Sensitization to Cephalosporins in HCW AAIR 
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cephalosporins and HSA alone were incubated overnight with 
50 μL of three-fold diluted serum samples from subjects who 
had high levels of specific IgE antibodies to any cephalosporin-
HSA conjugate. These mixtures were subjected to ELISAs, as 
described previously. The percentage of inhibition was calcu-
lated as follows: % inhibition=100×(1-[absorbance with inhib-
itor/absorbance without inhibitor]).
Statistical analysis
All statistical analyses were performed using SPSS ver. 12.0  
(SPSS Inc., Chicago, IL, USA). The χ2 test, Fisher’s exact test, and 
one-way analysis of variance (ANOVA) followed by a post-hoc 
Bonferroni correction, were used to compare data between the 
three study groups. Cross-tabulation analysis and independent 
t-tests were used to evaluate associations between the charac-
teristics of study subjects, work-related symptoms, SPT results, 
and specific IgE antibodies to cephalosporins. Multivariate lo-
gistic regression analysis was used to evaluate the risk factors 
for work-related symptoms, positive SPTs, and presence of se-
rum specific IgE antibody to cephalosporin-HSA conjugates. A 
value of P<0.05 was considered statistically significant.
RESULTS
Clinical characteristics of the study subjects
The number of male subjects was significantly higher in the 
healthy controls (25/86; 29.1%) than in HCW (1/161; 0.6%). The 
mean age was significantly younger in the healthy controls 
(22.2±3.2 years) than in HCW (27.4±4.3 years). Among HCW, 
the mean age was significantly greater in group II nurses (32.1±
3.5 years) than in group I nurses (26.8±4.2 years) or pharma-
cists (27.6±3.6 years). No subject used any protective equip-
ment when handling cephalosporins. All subjects were non-
smokers. The duration of employment was also significantly 
longer in group II nurses (298±93 months) than in group I 
nurses (151±127 months) or pharmacists (133±135 months). 
The personal histories of allergic diseases or antibiotic allergies 
in the three groups did not differ significantly (Table 1).
Table 1.  General characteristics of the study subjects
Nurses Pharmacists  
(n=23)
Total  
(n=161) Group I (n=125) Group II (n=13)
Gender, male (%) 0 (0.0%)  0 (0.0%)  1 (4.3%)  1 (0.6%) 
Age (year)* 26.8±4.2 32.1±3.5
† 27.6±3.6 27.4±4.3
Duration of employment (month)* 151±127 298±93
† 133±135 155±131
Personal history of allergic diseases 55 (44.0%) 6 (46.2%) 13 (56.5%) 74 (46.0%)
Bronchial asthma 19 (15.2%) 2 (15.4%) 4 (17.4%) 25 (15.5%)
Allergic rhinitis 36 (28.8%) 5 (38.5%) 8 (34.8%) 49 (30.4%)
Atopic dermatitis 8 (6.2%) 0 (0.0%) 3 (8.7%) 10 (6.2%)
Chronic urticaria 5 (4.0%) 0 (0.0%) 1 (4.3%) 6 (3.7%)
Personal history of antibiotic allergy 4 (3.2%) 1 (7.7%) 1 (4.3%) 6 (3.7%)
Cephalosporin-associated WRS 23 (18.4%) 3 (23.1%) 2 (8.7%) 28 (17.4%)
Upper/lower respiratory symptoms 19 (15.2%) 3 (23.1%) 2 (8.7%) 24 (14.4%)
Cutaneous symptoms 7 (5.6%) 0 (0.0%) 0 (0.0%) 7 (4.3%)
Anaphylaxis  1 (0.8%) 0 (0.0%) 0 (0.0%) 1 (0.6%)
Duration of latent period (month)* 31.4±38.6 42.0±25.5 5.8±5.0 27.4±4.3
Atopy (presence, %) 54 (43.2%) 2 (15.4%) 7 (30.4%) 63 (39.1%)
Positive SPT response to  3 (2.4%) 1 (7.7%) 1 (4.3%) 5 (3.1%)
any cephalosporin
Total IgE antibody level (kU/L)*  172±484 112±190 109±127 158±433
Specific IgE antibodies to Any cephalosporin-HSA conjugate 22 (17.6%) 2 (15.4%) 4 (17.4%) 28 (17.4%)
Cefotiam-HSA conjugate 13 (10.4%) 1 (7.7%) 1 (4.3%) 15 (9.3%)
Ceftriaxone-HSA conjugate 8 (6.4%) 1 (7.7%) 2 (8.7%) 11 (6.8%)
Ceftizoxime-HSA conjugate 2 (1.6%) 1 (7.7%) 3 (12.0%)
‡ 6 (3.7%)
Data are expressed as the number of subjects and percentage in parentheses.
*Data are expressed as mean±SD.
†Statistical analysis was performed using Chi-square or Fisher’s exact tests to compare the three groups.
‡P value <0.05 by Fisher’s exact test.
Group I, currently exposed group; Group II, previously exposed group; SPT, skin prick test; WRS, work-related symptoms; HSA, human serum albumin. Kim et al.
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rin-HSA conjugates were 17.4% for any cephalosporin, 10.4% for 
cefotiam, 6.8% for ceftriaxone, and 3.7% for ceftizoxime (Table 
1). There was no significant difference in the atopy rate between 
the positive and negative groups for specific IgE to the cephalo-
sporin-HSA conjugates. The prevalence of specific IgE to cefoti-
am tended to be higher in group I than in group II, but no sig-
nificant difference was found in the prevalence of specific IgE 
to cefotiam and ceftriaxone-HSA conjugates among the three 
groups. The prevalence of serum specific IgE to ceftizoxime-HSA 
conjugate was significantly higher in pharmacists (12.0%) than 
in groups I or II (1.6 and 7.7%, respectively; Fisher’s exact test). 
ELISA inhibition tests of the three cephalosporin-HSA conju-
gates demonstrated significant dose-dependent inhibition after 
addition of both free and conjugated forms of the correspond-
ing cephalosporins (Fig. 2). 
Risk factors for cephalosporin-associated work-related 
symptoms and for presence of serum specific IgE antibodies to 
cephalosporins
Based on a multivariate logistic regression analysis, a personal 
history of antibiotic allergy was a significant risk factor for the 
presence of cephalosporin-associated work-related symptoms 
(OR, 24.93; 95% CI, 2.61-238, Table 2), but not for the presence 
of serum specific IgE antibodies to cephalosporins (OR, 0.9; 95% 
CI, 0.18-4.53, data not shown). Additionally, a personal history 
of atopic dermatitis was a significant risk factor for the presence 
of serum specific IgE antibody to cefotiam-HSA conjugate (OR, 
6.30; 95% CI, 1.23-32.3, Table 3), while no risk factor was signifi-
cantly associated with the other cephalosporin-HSA conjugates 
or positive cephalosporin SPT results (data not shown).
Work-related symptoms
The overall prevalence of work-related symptoms associated 
with cephalosporin exposure in HCW was 17.4%. The most 
common symptoms were upper and/or lower respiratory 
(14.4%), followed by cutaneous (4.3%) and anaphylaxis (0.6%). 
The prevalence of work-related symptoms and the duration of 
latent periods of HCW did not differ significantly between the 
three groups (Table 1). There were no significant associations 
between the presence of cephalosporin-associated work-relat-
ed symptoms and the results of SPT or serum specific IgE anti-
bodies to any cephalosporin (data not shown).
Skin prick tests and atopic status
There was no significant difference in the atopy rate between 
the three groups of HCW. SPT using cephalosporins demon-
strated that five subjects (3.1%) had positive responses to ceftri-
axone, which was the only cephalosporin that elicited positive 
SPT responses. There was no significant difference in the prev-
alence of positive SPT responses between the three groups. 
There was no significant difference in atopy rate between posi-
tive and negative groups on SPT to the cephalosporins (60% and 
38.5% respectively, Fisher’s exact test).
Serum total and specific IgE antibodies to cephalosporin-HSA 
conjugates and competitive ELISA inhibition tests 
The mean serum total IgE level was 158±433 kU/L, and there 
was no significant difference in serum total IgE levels among 
the three groups (Table 1). The serum specific IgE levels to the 
three cephalosporin-HSA conjugates are shown in Fig. 1. The 
prevalence of detection of specific IgE antibodies to cephalospo-
Fig. 1.  Levels of serum specific IgE antibody to three cephalosporin-human serum albumin (HSA) conjugates in health care workers () and unexposed non-atopic 
healthy controls (). (A) cefotiam-HSA conjugate. (B) Ceftriaxone-HSA conjugate. (C) Ceftizoxime-HSA conjugate. Horizontal dashed lines indicate cut-off values 
(mean±three SD). Horizontal bars next to individual plots represent the mean values of each group. 
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DISCUSSION
A beta-lactam antibiotic sensitization rate of 2.6% as measured 
by SPT was reported in nurses working in a tertiary hospital.
12 
One study reported that the sensitization rate by SPT and intra-
dermal (ID) tests to benzylpenicilloyl polylysine (PPL) and a 
mixture of minor antigenic determinants (MDM) was 12% in 83 
asymptomatic Turkish nurses.
13 Prick and intradermal penicil-
lin sensitivity tests reported rates of 22% for PPL, 21% for MDM, 
43% for amoxicillin, and 33% for ampicillin in patients with a 
clinical history of urticaria and/or anaphylaxis.
16 Regarding skin 
test sensitivity to cephalosporin, to our knowledge there is no 
published report based on a large cohort.
17 In this study, we did 
not perform the ID test as it is too invasive and time-consuming 
to be used in a large cohort; moreover, its sensitivity is inade-
quate for the detection of sensitized subjects.
18 Instead, we de-
veloped an ELISA system for detecting serum IgE specific to 
commonly prescribed cephalosporins, such as cefotiam, ceftri-
axone, and ceftizoxime, and found an overall sensitization rate 
of 17.4%, while the sensitization rate by SPT was 3.1%. This in-
dicates that the ELISA is sufficiently sensitive to screen for symp-
tomatic or asymptomatic sensitized HCW. We focused on the 
rate of sensitization to cephalosporins, not penicillin, because 
the rate of penicillin prescription has been low in recent years 
in our hospital.
The sensitization rate of cephalosporin by SPT may be lower 
than that of penicillin. This may be due to the structural differ-
ences between these compounds. Penicillin can be easily hap-
tenized with proteins through its unstable pentagonal thiazoli-
dine ring, while cephalosporin shows relatively slow hapteniza-
tion because of its stable hexagonal dihydrothiazine ring.
19 
Therefore, the rate of positive cephalosporin SPT was lower in 
this study because the three cephalosporins tested may not 
have formed conjugates in the skin during the SPT. In contrast, 
use of cephalosporins already conjugated to HSA to detect se-
rum specific IgE antibodies resulted in a higher prevalence. The 
discrepancy between specific IgE measurements and SPT may 
be derived from differences in the protein binding properties of 
the cephalosporins tested. In the present study, ceftriaxone was 
Table 2.  Risk factors for the presence of cephalosporin-associated work-relat-
ed symptoms
Independent variables OR 95% CI P
Duration of employment 1.00 1.00-1.00 NS
Exposure intensity 0.77 0.34-1.79 NS
Personal history of atopic dermatitis 0.00 0.00-NA NS
Personal history of antibiotic allergies 24.93 2.61-238 0.005
Atopy 1.28 0.48-3.37 NS
Presence of specific IgE antibodies to 
any cephalosporin
1.27 0.39-4.12 NS
P values were obtained by multivariate logistic regression analysis. 
CI, confidence interval; HSA, human serum albumin; OR, odds ratio.
Table 3.  Risk factors for the presence of serum specific IgE antibodies to cefo-
tiam-human serum albumin (HSA) conjugate
Independent variables OR 95% CI P
Duration of employment 1.00 1.00-1.06 NS
Exposure intensity 1.21 0.43-3.37 NS
Personal history of atopic dermatitis 6.30 1.23-32.3 0.029
Personal history of antibiotic allergies 1.00 0.00-0.00 NS
Atopy 0.45 1.00-1.00 NS
P values were obtained by multivariate logistic regression analysis.
CI, confidence interval; HSA, human serum albumin; OR, odds ratio.
Fig. 2.  Results of competitive ELISA inhibition tests for serum specific IgE antibodies to cephalosporin-human serum albumin (HSA) conjugates, free cephalosporins 
and HSA alone (◇). (A) Inhibition of the cefotiam-HSA conjugate. Significant inhibitions were noted with both conjugated (●) and free (○) cefotiam in dose-depen-
dent manners. (B) Inhibition of the ceftriaxone-HSA conjugate. Significant inhibitions were noted with both conjugated (▲) and free (△) ceftriaxone in dose-depen-
dent manners. (C) Inhibition of the ceftizoxime-HSA conjugate. Significant inhibitions were noted with both conjugated (■) and free (□) ceftizoxime in dose-depen-
dent manners.
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the only cephalosporin that generated a positive SPT response, 
likely because the protein binding ratio of ceftriaxone in plasma 
is higher (90-95%) than that of the other cephalosporins, which 
may more readily induce a positive response during SPT. More-
over, the specificities of the IgE antibodies to the three cephalo-
sporins could be confirmed by ELISA inhibition tests, in which 
significant inhibition by both the free and conjugated forms of 
each cephalosporin were noted. These findings indicate that 
the measurement of specific IgE antibodies to cephalosporins 
using various cephalosporin-HSA conjugates is a useful meth-
od screening for sensitized subjects in a large HCW cohort.
When we determined the prevalence of serum specific IgE to 
three cephalosporins, that of cefotiam was the highest (9.3%), 
followed by ceftriaxone (6.8%) and ceftizoxime (3.7%). When 
we analyzed the cephalosporin prescription pattern in the 
months prior to this investigation, ceftriaxone was the most fre-
quently prescribed (24%), followed by cefotiam (9%), and cefti-
zoxime (7%). Moreover, exposed workers could be sensitized to 
cefotiam via two routes, inhalation and skin contact, as suggest-
ed by previous investigations,
3-5 because cefotiam develops more 
foam and evaporates more easily than other intravenous anti-
biotics during preparation of injections. Among nurses, the 
prevalence of specific IgE to cefotiam-HSA conjugate tended to 
be higher in group I than in group II, but this difference was not 
statistically significant. Although there have been a few case re-
ports describing the detection of serum specific IgE to cefotiam-
HSA conjugate in contact urticaria or anaphylaxis patients,
13 
this study is the first to investigate the cefotiam sensitization 
status of HCW in a single hospital setting. Our results showed 
that cefotiam is the most common sensitizing cephalosporin in 
exposed HCW.
Although we were unable to measure dust concentrations in 
the workplace using personal air samplers, many workers might 
be sensitized via either inhalation or skin contact. Additional 
details regarding the relative contributions of these routes may 
have been obtained if the degree of exposure intensity in the 
different work environments could have been determined. 
Moreover, this is the first investigation in exposed HCW to mea-
sure serum specific IgEs levels to ceftriaxone and ceftizoxime 
by ELISA. The prevalence of specific IgE antibodies to ceftizox-
ime-HSA conjugate was significantly higher in pharmacists 
than in nurses. Pharmacists are likely exposed to cephalospo-
rins while performing procedures such as grinding tablets or 
pouring syrup. They may also be sensitized while handling 
cephalosporins that share similar structures and cross-react 
with ceftizoxime. However, this conclusions may be a type I er-
ror, because only three pharmacists showed high serum specif-
ic IgE antibody levels to ceftizoxime-HSA conjugate. Further 
studies are needed to monitor changes in serum specific IgE to 
each cephalosporin in addition to symptom development.
Exposure to cephalosporin powders may have induced vari-
ous occupational IgE-mediated allergies, as reported for work-
ers with positive SPT or high levels of serum specific IgE anti-
bodies to corresponding cephalosporin-HSA conjugates.
3-7,10,11 
Contact urticaria syndrome was associated with positive SPT to 
beta-lactam antibiotics in nurses.
12 Although we previously re-
ported a patient with occupational anaphylaxis who had a high 
serum level of cefotiam-HSA conjugate,
3 no significant associa-
tion between the presence of cephalosporin-associated work-
related symptoms and the results of SPT or serum specific IgE 
antibodies to any cephalosporin was found. Furthermore, no 
significant associations with duration of employment, intensity 
of exposure, and personal history of allergic diseases were 
found. 
In this study, a significant risk factor for the presence of ceph-
alosporin-associated work-related symptoms was a personal 
history of previous antibiotic allergies. This is similar to previ-
ous studies, wherein a past history of drug allergy was a risk fac-
tor for contact urticaria syndrome due to beta-lactam antibiot-
ics.
12 Our analysis of the factors associated with the presence of 
serum specific IgE antibodies to cefotiam-HSA conjugate de-
termined that a personal history of atopic dermatitis was a risk 
factor. Contact urticaria syndrome is a major manifestation of 
cefotiam-induced occupational allergic diseases.
4,12,20,21 Atopic 
dermatitis was seen in most of these reports, since it is a major 
clinical manifestation of cefotiam contact and may have facili-
tated sensitization. In this study, we confirmed by personal in-
terview that nurses with a history of atopic dermatitis had the 
condition a number of years before beginning their nursing ca-
reer. In some nurses, atopic dermatitis recurred or a pre-exist-
ing atopic dermatitis became worse after beginning their em-
ployment. Additional investigations are needed to evaluate the 
role of protective equipment, especially gloves, in preventing 
sensitization and development of contact urticaria syndrome 
after cefotiam exposure.
In conclusion, we developed an ELISA for the detection of se-
rum specific IgE antibodies to three cephalosporins and found 
an IgE sensitization rate of 17.4% in HCW exposed to cephalo-
sporins. Atopic dermatitis may be a risk factor for cefotiam sen-
sitization.
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